Following transient middle cerebral artery occlusion (tMCAO), treatment with HGF/AAV-transduced DPSCs (HGF-DPSCs) was more effective than with untransduced DPSCs, as demonstrated by the attenuation of brain damage and improvement in neurological recovery. This evidence concerns the gene HGF and medical procedure.